| Lebanon 2023 © Carmen Yahchouchi/MSF |
| Some 80 percent of people with diabetes live in countries where insulin pens are priced out of reach. |
Doctors Without Borders/Médecins Sans Frontières (MSF) calls on Eli Lilly, Novo Nordisk, Sanofi, and all other insulin manufacturers to make insulin pen injection devices available at $1 per pen everywhere, including in low- and middle-income countries.
Insulin pens could cost as little as $0.94 each to produce and still be profitable for the companies, according to MSF research. Pen prices now vary wildly around the globe—and are currently $1.99 per device in South Africa, $5.77 in India, $14.00 in the Philippines, and $90.69 in the US. Eli Lilly, Novo Nordisk, and Sanofi monopolize the diabetes market, so they can set prices as high as they want.
“Only about half of people around the world who need insulin can access it,” said Dr. Helen Bygrave, non-communicable diseases advisor for MSF’s Access Campaign. “It’s devastating that today pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi are maintaining this double standard in access to diabetes care.”
Read more>> |
|
We invite you to participate in a virtual mapathon on Tuesday, November 19, from 6:00 to 8:00 p.m. ET. Volunteers will map parts of the world most affected by humanitarian crises so we can deliver aid where it's needed. Join here >> | | | |
